Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Vincerx Pharma, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 49 | 43 | −6 |
| Shares | 13.9M | 14.5M | +580.3K (+4.2%) |
| Value | $18.4M | $20.0M | +$1.63M (+8.9%) |
New holders (5)
Institutions that held Vincerx Pharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Russell Investments Group, Ltd. | 206,224 | $284.0K | 0.00% |
| Two Sigma Securities, LLC | 26,786 | $37.0K | 0.01% |
| Ground Swell Capital, LLC | 15,000 | $21.0K | 0.06% |
| UBS Group AG | 1,567 | $2.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 597 | $824 | 0.00% |
Sold out (11)
Institutions that held Vincerx Pharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Pura Vida Investments, LLC | 108,459 | $143.0K |
| Sphera Funds Management Ltd. | 70,467 | $93.0K |
| Susquehanna International Group, LLP | 17,552 | $23.0K |
| The PNC Financial Services Group, Inc. | 10,000 | $13.0K |
| Penserra Capital Management LLC | 6,679 | $8.00K |
| Legal & General Group Plc | 1,358 | $2.00K |
| Point72 Hong Kong Ltd | 707 | $1.00K |
| New York State Common Retirement Fund | 153 | $0 |
| Credit Suisse AG | 9 | $0 |
| Citigroup Inc | 163 | $0 |
| Advisor Group Holdings, Inc. | 291 | $0 |